Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CHAMP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
FLJ25758 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
RTCA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ENAH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLPP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FCER1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM33 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ASAH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARHGEF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACVR2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF407 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LYPLAL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SASS6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAIP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCNT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRKAA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on